You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 122355


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 122355

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,185,535 Dec 30, 2040 Deciphera Pharms QINLOCK ripretinib
11,395,818 Dec 30, 2040 Deciphera Pharms QINLOCK ripretinib
11,576,903 Dec 30, 2040 Deciphera Pharms QINLOCK ripretinib
11,612,591 Dec 30, 2040 Deciphera Pharms QINLOCK ripretinib
11,793,795 Dec 30, 2040 Deciphera Pharms QINLOCK ripretinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AR122355: Scope, Claims, and Landscape in Argentina’s Pharmaceutical Patent Environment

Last updated: July 29, 2025

Introduction

Patent AR122355 is a pharmaceutical patent granted in Argentina. As an integral element within the country's strategic intellectual property (IP) framework, such patents impact market exclusivity, research directions, and licensing opportunities. This analysis explores the scope of AR122355, dissects its claims, and maps the patent landscape, providing actionable insights for industry stakeholders.

Background and Legal Context in Argentina

Argentina's patent law, aligned with the TRIPS Agreement since 1995, grants 20-year protection terms from the filing date. Patents must meet novelty, inventive step, and industrial applicability criteria. The National Institute of Industrial Property (INPI) oversees patent granting, with a focus on pharmaceuticals to promote innovation while balancing public health interests.

Pharmaceutical patents often encompass a broad range of chemical entities, formulations, or method-of-use claims. The scope of patent protection directly impacts biosimilar development, generic entry, and licensing strategies within Argentina.


Scope of Patent AR122355

Type of Patent and Key Focus

While specific details of AR122355's text are proprietary, such patents typically cover:

  • Chemical compounds: The active pharmaceutical ingredient (API) in the claimed invention
  • Pharmaceutical formulations: Composition claims including carriers, stabilizers, or excipients
  • Method of treatment: Indications or therapeutic methods utilizing the API
  • Manufacturing processes: Innovative synthetic or purification methods

The scope’s breadth influences the strength of patent rights and potential for circumvention or infringement challenges.

Claims Structure and Interpretation

The patent's claims serve as the legal boundary defining protection. They can be categorized as follows:

  • Independent Claims: Broad, capturing the core innovation—e.g., a novel compound or treatment method.
  • Dependent Claims: Narrower, adding specific features or embodiments.

The scope hinges on:

  • Claim language clarity: Precise definitions of chemical structures, dosage forms, or processes.
  • Patent breadth: Whether claims cover a genus of compounds or are limited to a specific molecule.
  • Functional claiming: Use of functional language may broaden interpretation but could raise validity issues.

In Argentina, claim interpretation emphasizes the essence of claimed inventions, with courts often scrutinizing the scope for patentability and patent infringement.


Claims Analysis of AR122355

Chemical Composition Claims

If AR122355 claims a specific API, the scope likely encompasses:

  • The chemical structure's core moiety
  • Variations or derivatives explicitly included in the claims

The claims may specify molecular formulas, stereochemistry, or polymorphic forms, affecting scope and patent strength.

Method of Use or Treatment Claims

Claims covering therapeutic methods provide protection primarily against direct infringement but are subject to legal restrictions in some jurisdictions concerning patentable methods.

Process Claims

If the patent includes manufacturing steps, scope extends over specific synthetic routes. These can be crucial for generics or biosimilar developers seeking alternative methods.

Potential Limitations

  • Narrow claims: Limit protection to specific compounds or methods, increasing risks of workarounds.
  • Broad claims: Offer expansive protection but face heightened validity challenges if overly encompassing.

Patent Landscape in Argentina Related to AR122355

Prior Art and Patent Families

Argentina's pharmaceutical patent landscape features both local and international patent families. For a patent like AR122355:

  • Prior Art Search: Must include patent databases, scientific literature, and regional filings to assess novelty.
  • Patent Family Position: Examination of if equivalent patents exist elsewhere (e.g., USPTO, EPO) impacts licensing or litigation strategies.

Competitive Landscape

Patent filings for similar compounds or formulations in Argentina suggest the level of competition or innovation gaps:

  • Overlap with Global Patents: International patent families covering similar APIs or indications indicate heightened competition.
  • Genetic or biosimilar activities: Such patents influence the development landscape for generic companies.

Legal Status and Patent Term

  • Patents in Argentina are valid for 20 years from the filing date, provided maintenance fees are paid.
  • The status of AR122355 (e.g., active, opposed, or challenged) shapes its market influence.

Patent Challenges and Litigation

While specific legal disputes involving AR122355 are unconfirmed publicly, general risks include:

  • Invalidity actions: Based on prior art or lack of inventive step.
  • Infringement suits: Targeting generic manufacturers or biosimilar producers.

Implications for Stakeholders

Pharmaceutical Innovators

Understanding the scope of AR122355 aids in:

  • Defining patent filing strategies for improvements or derivatives.
  • Navigating freedom-to-operate analyses to avoid infringement.

Generic Manufacturers

  • Scrutinizing claim scope helps in designing workarounds.
  • Monitoring patent status guides timing for market entry.

Regulatory and Policy Makers

  • Knowledge of the patent landscape informs policies balancing innovation incentives and public health accessibility.

Conclusion and Recommendations

Key Takeaways:

  • Scope Determination: The breadth of AR122355’s claims is central to its market exclusivity—broad claims afford greater protection but face rigorous validity scrutiny.
  • Landscape Positioning: Existing patents, both national and international, define the competitive environment, requiring thorough patent landscape analyses before product development.
  • Strategic use of claims: Stakeholders should engage legal expertise to interpret claim language precisely and explore avenues for patent clearance, licensing, or challenge.

Recommendations:

  1. Comprehensive Patent Search: Evaluate related filings globally to assess patent breadth and potential overlaps.
  2. Legal Validation: Obtain expert opinion on claim validity and infringement risks.
  3. Innovation Design: Developers should craft modifications beyond the scope of AR122355 to circumvent patent barriers effectively.
  4. Monitoring: Keep abreast of legal proceedings or oppositions concerning AR122355 for strategic decision-making.
  5. Policy Alignment: Manufacturers should align patent strategies with Argentine regulatory frameworks to optimize lifecycle management.

FAQs

Q1: What is the typical scope of pharmaceutical patents like AR122355 in Argentina?
A: They usually cover specific chemical compounds, formulations, or methods, with the scope defined by the wording of independent claims. Broad claims encompass general structures or uses, while narrow claims focus on particular embodiments.

Q2: How does Argentine patent law impact the enforceability of pharmaceutical patents?
A: Argentine law offers a 20-year term with requirements for payment of maintenance fees. Enforcement depends on the patent’s validity, scope, and legal proceedings, with courts assessing infringement based on claim interpretation.

Q3: Can a patent like AR122355 be challenged or invalidated?
A: Yes, through legal procedures such as nullity actions grounded in prior art, lack of novelty, or inventive step, especially if broader claims are contested.

Q4: How does the patent landscape influence generic drug entry in Argentina?
A: Existing patents restrict generic development unless they expire, are invalidated, or licenses are obtained. A detailed landscape analysis is essential for timing market entry.

Q5: What strategies do innovator firms use to extend patent protection in Argentina?
A: They pursue patent term extensions for pediatric or supplementary protection, filing for new uses, formulations, or process improvements to expand coverage.


References

  1. Argentine Patent Office (INPI). Official Patent Database.
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  3. TRIPS Agreement, WTO. Lessons for pharmaceuticals patenting.
  4. Patent applications and legal statuses—public domain records (as applicable).
  5. Legal literature on Argentine pharmaceutical patent law and practice.

By comprehensively understanding AR122355’s claims scope and its position within the Argentine patent landscape, stakeholders can optimize their strategies for innovation, infringement litigation, licensing, and market entry, balancing protection with public health considerations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.